These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 16223936)

  • 1. In vitro activities of 11 fluoroquinolones against 226 Campylobacter jejuni strains isolated from Finnish patients, with special reference to ciprofloxacin resistance.
    Lehtopolku M; Hakanen AJ; Siitonen A; Huovinen P; Kotilainen P
    J Antimicrob Chemother; 2005 Dec; 56(6):1134-8. PubMed ID: 16223936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance in Campylobacter jejuni strains collected from Finnish patients during 1995-2000.
    Hakanen AJ; Lehtopolku M; Siitonen A; Huovinen P; Kotilainen P
    J Antimicrob Chemother; 2003 Dec; 52(6):1035-9. PubMed ID: 14613954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of 11 fluoroquinolones against 816 non-typhoidal strains of Salmonella enterica isolated from Finnish patients with special reference to reduced ciprofloxacin susceptibility.
    Kotilainen P; Pitkänen S; Siitonen A; Huovinen P; Hakanen AJ
    Ann Clin Microbiol Antimicrob; 2005 Sep; 4():12. PubMed ID: 16143044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Susceptibility of Campylobacter jejuni clinical isolates from children to eight antibiotics].
    García-Campos JA; Alarcón T; Domingo D; Menéndez-Rivas M; López-Brea M
    Rev Esp Quimioter; 2003 Jun; 16(2):216-20. PubMed ID: 12973460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant prevention concentration of ciprofloxacin, enrofloxacin and nalidixic acid against Campylobacter jejuni.
    Pasquali F; Lucchi A; Manfreda G
    Int J Antimicrob Agents; 2008 May; 31(5):500-2. PubMed ID: 18329250
    [No Abstract]   [Full Text] [Related]  

  • 6. [Resistance monitoring working group: resistance to erythromycin, ciprofloxacin, and tetracycline in human isolates of Campylobacter spp. in the Czech Republic tested by the EUCAST standard method].
    Žemličková H; Jakubů V; Marejková M; Urbášková P
    Epidemiol Mikrobiol Imunol; 2014 Sep; 63(3):184-90. PubMed ID: 25412481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolones.
    McDermott PF; Bodeis SM; English LL; White DG; Walker RD; Zhao S; Simjee S; Wagner DD
    J Infect Dis; 2002 Mar; 185(6):837-40. PubMed ID: 11920303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of older and newer fluoroquinolones against efflux-mediated high-level ciprofloxacin-resistant Streptococcus pneumoniae.
    Daporta MT; Muñoz Bellido JL; Guirao GY; Hernández MS; García-Rodríguez JA
    Int J Antimicrob Agents; 2004 Aug; 24(2):185-7. PubMed ID: 15288320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).
    Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2007 May; 58(1):27-32. PubMed ID: 17383140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of sitafloxacin compared with several fluoroquinolones against Streptococcus anginosus and Streptococcus constellatus.
    Yamamoto N; Fujita J; Shinzato T; Higa F; Tateyama M; Tohyama M; Nakasone I; Yamane N
    Int J Antimicrob Agents; 2006 Feb; 27(2):171-3. PubMed ID: 16417990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistance of Campylobacter jejuni and Campylobacter coli clinical isolates from Poland.
    Wardak S; Szych J; Zasada AA; Gierczynski R
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1123-5. PubMed ID: 17210776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-level fluoroquinolone resistance among Campylobacter jejuni isolates in Australia.
    Unicomb LE; Ferguson J; Stafford RJ; Ashbolt R; Kirk MD; Becker NG; Patel MS; Gilbert GL; Valcanis M; Mickan L;
    Clin Infect Dis; 2006 May; 42(10):1368-74. PubMed ID: 16619147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant prevention concentrations of fluoroquinolones against Campylobacter jejuni isolated from chicken.
    Wang L; Yuanshu Z; Yuhan Z; Yaojie ; Yingxia L
    Vet Microbiol; 2010 Aug; 144(3-4):409-14. PubMed ID: 20226601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates.
    Feodoroff FB; Lauhio AR; Sarna SJ; Hänninen ML; Rautelin HI
    Clin Microbiol Infect; 2009 Feb; 15(2):188-92. PubMed ID: 19154485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates.
    Rodríguez-Avial I; Rodríguez-Avial C; López O; Culebras E; Picazo JJ
    Int J Antimicrob Agents; 2006 Apr; 27(4):303-6. PubMed ID: 16540293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative antimicrobial activity of gatifloxacin tested against Campylobacter jejuni including fluoroquinolone-resistant clinical isolates.
    Hayward CL; Erwin ME; Barrett MS; Jones RN
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):99-102. PubMed ID: 10354858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains.
    Jones RN; Critchley IA; Whittington WL; Janjic N; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):311-7. PubMed ID: 16269221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous mutation frequency and emergence of ciprofloxacin resistance in Campylobacter jejuni and Campylobacter coli.
    Hänninen ML; Hannula M
    J Antimicrob Chemother; 2007 Dec; 60(6):1251-7. PubMed ID: 17911389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of topoisomerase mutations in fluoroquinolone-resistant and -susceptible Campylobacter jejuni strains isolated in Senegal.
    Kinana AD; Cardinale E; Bahsoun I; Tall F; Sire JM; Garin B; Boye CS; Dromigny JA; Perrier-Gros-Claude JD
    Int J Antimicrob Agents; 2007 Apr; 29(4):397-401. PubMed ID: 17224260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.